The cytotoxic cellular immunity is considered an essential first line defense against SARS-CoV-2 infection (19) and the early development of cytotoxic CD8+ T cells correlates with effective viral clearance and mild disease (20, 21), being the absence of effector CD8+ T cells one major cause of COVID-19 mortality (8). The gene discussed is CD8A; the disease is COVID-19.